GSK3 inhibitors might also have the potential for neurodegenerative disorders, such as Alzheimer's disease. Glycogen synthase kinase 3 (GSK3) inhibitor library contains 479 compounds.
Life Chemicals has designed a new Tyrosine Kinase Screening Library of about 5,700 drug-like screening compounds offered for high throughput screening (HTS).